Introduction
Ion channels are vitally important for the excitability, electrical activity and signaling properties of most cell types in the body; this is perhaps most obvious in cells of the nervous system, particularly neurons. Voltage-gated K + (K v ) channels belong to the structurally and functionally highly diverse K + channel gene superfamily, which comprises more than 70 genes in the human, with splice variants adding further diversity [Yellen, 2002] . K v channels are the molecular brakes of neuronal signaling; they sense depolarization and act to terminate action potentials. By limiting neuronal excitability, they also have a fundamental influence on neuronal coding.
M currents are low-threshold, slowly activating/deactivating, voltage-and time-dependent potassium cur-rents that show no inactivation. The currents were named M for 'muscarinic' due to their suppression by muscarinic receptors activation in bullfrog sympathetic ganglion neurons [Brown and Adams, 1980] . M currents have been recorded in a number of preparations from central and peripheral nervous tissue, e.g. in hippocampus [Moore et al., 1988] , and in the visual system [Beech and Barnes, 1989] . In superior sympathetic ganglia and some hippocampal neurons, M channels consist of tetrameric assemblies of KCNQ2 and KCNQ3 subunits [Wang et al., 1998 ]. Such M channels regulate membrane potential, neuronal excitability and limit repetitive firing, thus opposing epileptic activity. Gene mutations of either KCNQ2 or KCNQ3 lead to inherited forms of epilepsybenign familial neonatal convulsions, BFNC1 ] and BFNC2 ], respectively. KCNQ5 [Lerche et al., 2000; Schroeder et al., 2000] add to the M channel subunit repertoire, and isoforms resulting from alternative splicing also contribute to M current diversity [see review by Jentsch, 2000 ].
An array of ion channels and transport proteins permeable to potassium ions (K + ) are known to exert a major influence on several processes in cochlear physiology and auditory function [Wangemann, 2002] . Electrochemical gradients of K + ions and transmembrane K + ion channels are essential for sound transduction by sensory hair cells and neuronal signaling. Hearing disorders specifically associated with KCNQ genes include KCNQ1 and KCNQ4 . Mutations in KCNQ1 (as well as KCNE1 ) can lead to Jervell and Lange-Nielsen syndrome with congenital deafness resulting from faulty K + recycling via I sK current in marginal cells of stria vascularis [Neyroud et al., 1997] . Mutations in KCNQ4 which is mainly expressed in outer hair cells lead to autosomal-dominant progressive hearing loss, DFNA2 [Kubisch et al., 1999] ; alternatively, inner hair cell expression and the role of KCNQ4 in regulation of the resting potential and intracellular calcium concentration may underlie this inherited deafness [Oliver et al., 2003] . Kubisch et al. [1999] detected weak expression of KCNQ3 in mouse cochlea and vestibule. However, pathophysiological roles of KCNQ2 or KCNQ3 in the inner ear are as yet unknown.
We have recently recorded M-like currents from outer hair cells isolated from guinea pig cochlea, and confirmed that M channel subunit genes Kcnq2 and Kcnq3 are expressed in the cochlea [Liang et al., 2005] . Following that observation, we have identified expression of KCNQ1-5 subunit mRNAs in rat and guinea pig hearing organs [Liang et al., 2006] . The present study extends our work on the voltage-gated K + channel KCNQ subfamily (K v 7.x), with the identification of Kcnq2 and Kcnq3 gene expression in microdissected cochlear subregions, with the detection of Kcnq2 alternative splice variants in the rat cochlea, and with the immunolocalization of M channel subunits in cryo-sectioned cochlea using specific antibodies directed against KCNQ2 and KCNQ3.
Materials and Methods

Animal Use and Care
The animals (adult Sprague-Dawley rats, pigmented guinea pigs, and C57 BL/6 mice) and acute procedures used in this study were approved by the Karolinska Institutet ethics committee (N146/99, N10/01).
One-Step RT-PCR
The cochleas were quickly dissected out, and then further microdissected in RNAlater RNA stabilization reagent (Qiagen) under a dissection microscope. Cochlear subregions (modiolus, organ of Corti, and lateral wall) were immediately put in TRIzol (Invitrogen Corporation, Carlsbad, Calif., USA) and homogenized well. Total RNA was isolated from the cochlear fractions using the TRIzol and RNeasy MinElute Cleanup kits (Qiagen GmbH, Hilden, Germany) according to the manufacturers' instructions. The concentration and quality of total RNA was measured on an Agilent 2100 Bioanalyzer using the RNA 6000 Nano Assay (Agilent Technologies, Palo Alto, Calif., USA).
cDNA synthesis and PCR were performed using the SuperScript One-Step RT-PCR system (Invitrogen) in an MJ Research gradient thermocycler (PTC-200; Bio-Rad Laboratories, Inc., Waltham, Mass., USA). PCR primers were purchased from Invitrogen: Kcnq1 , forward 5 -GGATGGAGATTGTCCTGGTG-3 , reverse 5 -CCTGGCGATGGATGAAGA-3 ; Kcnq2 , forward 5 -CGTTCATCTACCACGCCTAC-3 , reverse 5 -TACTCCACGC-CAAACACCAC-3 ; Kcnq2_sv , forward 5 -TCACGCACCGAC -TGCACTC-3 , reverse 5 -CCTTCCCAAGCCGTCCCATC-3 ; Kcnq2_sv_new , forward 5 -TCCCCATCTACAGACTCATTCC-3 , reverse 5 -CCTCGGGGGCTTGGTGAT-3 ; Kcnq3 , forward 5 -CCAAGGAATGAACCATATGTAGCC-3 , reverse 5 -CAGAAG -AGTCAAGATGGGCAGGAC-3 [Kubisch et al., 1999] ; Myo7a , forward 5 -GCCGATTCCATCTTCCACTA-3 , reverse 5 -TCCG-TAGTTTGCTTCACCTC-3 ; Gapdh , forward 5 -GCCAACAT-CAAGTGGGGTGATG-3 , reverse 5 -GTCTTCTGGGTGGCAG -TGATG-3 . The optimal annealing temperature and cycle number for each primer pair are: Kcnq1 (62 ° C, 34 cycles), Kcnq2 (60 ° C, 32 cycles), Kcnq2_sv (64 ° C, 34 cycles), Kcnq2_sv_new (56 ° C, 34 cycles), Kcnq3 (50 ° C, 30 cycles), Myo7a (50 ° C, 34 cycles), Gapdh (60 ° C, 28 cycles). PCR products were separated by agarose gel electrophoresis, and directly sequenced after gel extraction with QIAquick Gel Extraction kit (Qiagen), using Amersham Pharmacia Biotech DYEnamic ET terminator cycle-sequencing kit (US81050), and an ABI100 model 377 sequencer (KIseq, the DNA-sequencing core at Karolinska Institutet).
Antibodies
The rabbit anti-KCNQ2N antibody is directed against residues from the N-terminal region of KCNQ2 (GEKKLKVGFVGLDP-GAPDSTRDC), which are conserved in mammals [Cooper et al., 2001] . The guinea pig anti-KCNQ3N antibody is developed against residues from the long N-terminal splice variant of KCNQ3 (AGDEERKVGLAPGDVEQVTLAL), which is also fully conserved in the mouse, the rat and humans. The antiserum was affinity-purified against the immunogenic peptide. The specificity of KCNQ3N antibody was examined by immunoblotting of cell lysates from human embryonic kidney (HEK) cells transfected with KCNQ2 or KCNQ3 cDNA, following the protocols as previously described [Cooper et al., 2001] . Mouse anti-Class III ␤ -tubulin ( ␤ III-tubulin) (TUJ1) antibody was used to label neuronal cells (Covance). The rabbit anti-KCNJ10 polyclonal antibody was purchased from Alomone Labs (Jerusalem, Israel).
Tissue Preparation and Immunohistochemistry
Animals were deeply anesthetized with an overdose of sodium pentobarbital and transcardially perfused with normal saline (0.9%) followed by ice-cold 4% formaldehyde fixative freshly prepared from paraformaldehyde. The cochleas were dissected, locally perfused and immersed in the same fixative at 4 ° C overnight, then decalcified in 0.1 M EDTA. Mouse brain was used as positive control for the KCNQ antibodies. The tissues were cryoprotected by submerging in sucrose solutions (10 and 30% sucrose in PBS, 24 h each), and finally embedded in OCT compound. Tissue blocks were stored at -80 ° C and sectioned at 12-m thickness using a cryostat (Leica).
Cryosections were processed for immunohistochemistry using immunofluorescence or the Avidin:Biotinylated enzyme Complex (ABC) method for detection. Sections for ABC staining were pretreated with 0.3% H 2 O 2 for 5 min to inactivate endogenous peroxidase. All sections were blocked with 5% goat serum, 5% BSA and 0.4% Triton X-100 in 0.1 M PBS for 1 h at room temperature, and further incubated overnight at 4 ° C with rabbit anti-KCNQ2N (1: 100) or guinea pig anti-KCNQ3N (1: 100) antibody. Mouse anti-TUJ1 (1: 250) and rabbit anti-KCNJ10 (1: 400) antibodies were applied in double fluorescent labeling. For immunofluorescence, the sections were incubated with fluorophore-conjugated secondary antibodies (Jackson Immunoresearch) and subsequently stained with DAPI (Molecular Probes) to visualize the nuclei. The sections were observed using a fluorescence microscope (Zeiss) or a confocal laser scanning microscope system (Zeiss LSM 510). For ABC staining, the sections were then incubated with biotinylated secondary antibody for 1 h, and ABC complex (Vector Labs) for 40 min at room temperature. Immunolabeling was visualized with diaminobenzidine (DAB) substrate (Vector Labs) and the nuclei were stained with Gill's hematoxylin. The sections were observed and photographed in a light microscope (Zeiss) equipped with a digital camera (Nikon Coolpix 990). Primary antibodies were omitted from slides used as negative controls.
Results
Differential Expression of Kcnq2 and Kcnq3 mRNA Transcripts in the Mammalian Cochlea
To compare the relative expression of Kcnq2 and Kcnq3 mRNA transcripts in the subregions of microdissected adult guinea pig cochlea, RT-PCR conditions were optimized within the linear amplification range. The primers were designed to span a region of transcript common to all the splice forms. As shown in figure 1 , strong expression of Kcnq2 was found in modiolus (containing the spiral ganglion), with lower levels in the organ of Corti, and absence in the cochlear lateral wall. In contrast, Kcnq3 was expressed in all cochlear subfractions, although the expression was lowest in the lateral wall. Myo7a and Kcnq1 primers were run in parallel to assess potential template contamination during the microdissection procedure, as Myo7a and Kcnq1 were exclusively detected in the organ of Corti and the cochlear lateral wall, respectively. Omission of RNA template or reverse transcriptase served as negative controls. Expression of the housekeeping gene Gapdh functioned as positive loading control and confirmed the quality of the RNA. All PCR products were sequence-verified. The Kcnq2 and Kcnq3 expression pattern was found to resemble that of RNA samples from adult rat and mouse cochlear subfractions.
Multiple alternative splice variants of the Kcnq2 gene have been identified in neuronal tissues, in which the major splicing events occurred in the long intracellular C- terminus. We designed a primer pair (Kcnq2_sv) in order to amplify all the different C-terminal splice variants. Five Kcnq2 alternative splicing isoforms were detected in the adult rat cochlea ( fig. 2 ): 4 isoforms (A, C, E, and H) which were also identified in rat brain and superior cervical ganglia (SCG) [Pan et al., 2001] , and a new (the shortest) isoform with exons 8, 11, 12a and 15a spliced out. All the cochlear splice variants contained the alternative 5 splice site in exon 13 (13a shown in fig. 2 ) but lacked exon 15a. We have also designed a primer pair (Kcnq2_sv_new) which specifically amplified only the new Kcnq2 isoform. The new Kcnq2 splice variant was abundantly expressed in several brain regions (e.g. hippocampus, cerebellum, cerebellar cortex; data not shown).
KCNQ2 Localization in the Mammalian Cochlea
The specificity of anti-KCNQ2N antibody was first confirmed in cryosections of mouse hippocampus (data not shown). It was consistent with previously reported intense staining in hippocampal mossy fiber pathways in the hilus of the dentate gyrus and stratum lucidum in CA3 [Cooper et al., 2001] . KCNQ2 immunoreactivity in guinea pig, rat ( fig. 3 A, B, and C), and mouse (data not shown) cochlea was observed in the cell bodies of primary auditory neurons of the spiral ganglion and their afferent projections at the base of inner hair cells, which were also immunolabeled by the anti-KCNQ2N antibody. KCNQ2 antibodies labeled the nerve fibers after entering through habenula perforata (where auditory afferents lose their myelin sheath). In the organ of Corti, there was pronounced staining beneath outer hair cells, possibly relating to afferent or efferent synapses, as well as weaker staining in the outer hair cells themselves. KCNQ2 immunoreactivity was also prominent in pillar cells. No KCNQ2 immunoreactivity was noticed in the cochlear lateral wall. Negative control sections with primary antibody omitted did not exhibit any significant immunolabeling ( fig. 3 D) .
Characterization of KCNQ3N Antibodies and KCNQ3 Localization in the Mammalian Cochlea
The anti-KCNQ3N immune serum was tested by using HEK cells transfected with KCNQ3 cDNA. The KCNQ3 band ( ; 90 kDa) was absent in preimmune serum, while immune serum detected the KCNQ3 protein.
After affinity purification, the anti-KCNQ3N antibody recognized a single predominant band of ; 90 kDa; this was abolished by pre-incubation of the antibodies with the KCNQ3 immunogenic peptide, whereas KCNQ3N antibodies still recognized the KCNQ3 band in the presence of KCNQ2 peptide ( fig. 4 A) .
Using the ABC immunoperoxidase staining method, KCNQ3 immunoreactivity in rat ( fig. 4 B) and mouse (data not shown) cochlea was observed in the spiral ganglion, both in neurons and, more pronounced, in the satellite cells surrounding the spiral ganglion neurons. KCNQ3 immunoreactivity was not present either in the organ of Corti or in the lateral wall. However, the subcellular localization of KCNQ3 in the spiral ganglion was not readily resolved at the current magnification level. Negative control sections with primary antibody omitted were virtually devoid of immunostaining ( fig. 4 C) . To determine what cell types in the spiral ganglion express KCNQ3 subunit proteins, double immunofluorescence staining of KCNQ3 with either a neuronal marker, TUJ1, or a specific satellite cell marker in the spiral ganglion, the KCNJ10 K + channel [Hibino et al., 1999; Jin et al., 2006] , were carried out ( fig. 4 D-I ). KCNQ3 immunostaining was clearly observed in the somata of spiral ganglion neurons ( fig. 4 D and G) , while it appeared more intensely as 'punctate rings' around the neurons, as seen in the overlay image of KCNQ3 and TUJ1 immunoreactivities ( fig. 4 F) . In addition, complete overlap of KCNQ3 and KCNJ10 immunoreactivities around the cell bodies of spiral ganglion neurons ( fig. 4 I) further demonstrated that KCNQ3 channel proteins were indeed expressed in the satellite cells.
Discussion
Following our recent reports on M currents in cochlear outer hair cells, and expression of Kcnq genes in the cochlea [Liang et al., 2005 [Liang et al., , 2006 , we here provide further evidence that the molecular correlates of M currents, KCNQ2 and KCNQ3 M channel subunits, are distributed in the cochlea.
By RT-PCR analysis, Kcnq2 and Kcnq3 mRNA transcripts were detected in cochlear sensorineural subregions (organ of Corti and spiral ganglion). Within these subregions, KCNQ3 is most likely coassembling with KCNQ2 or KCNQ4 to form functional heteromultimers. In addition, Kcnq3 transcripts were expressed in the cochlear lateral wall. Additional experiments, e.g. single-cell RT-PCR and RNA in situ hybridization, may be performed to further elaborate on the spatial localization of Kcnq2/Kcnq3 mRNA in the cochlea. A recent study showed expression of several spliced forms of Kcnq4 gene in the mouse cochlear lateral wall [Beisel et al., 2005] . These results suggest that KCNQ3/KCNQ4 channel subunits may play a role in the cochlear K + recycling pathway. The alternative splicing of the Kcnq2 gene has been previously described, producing several differentially spliced transcripts, predominantly in the C-terminal region [Nakamura et al., 1998; Pan et al., 2001] . These splice variants encode channel proteins which display distinct functional properties [Pan et al., 2001; Smith et al., 2001; Tinel et al., 1998 ]. Splicing mutations in KCNQ2 have been reported in patients with BFNC [de Haan et al., 2006; Lee et al., 2000] . We have detected 5 Kcnq2 splice isoforms in the rat cochlea, of which 4 isoforms (A, C, E and H) were also present in rat brain and SCG [Pan et al., 2001] . However, the splice isoforms which contained exon 15a, partially accounting for the slow deactivation-activation kinetics of M currents [Pan et al., 2001] , were not expressed in the rat cochlea. The new Kcnq2 isoform identified in the rat cochlea also existed in subregions of rat brain. The functional properties of channels encoded by this new isoform remain to be determined in future studies. The KCNQ2 antibodies used in this study were previously shown to exhibit widespread specific immunoreactivity in mouse brain, mapping in particular to key sites for control of rhythmic neuronal activity and synchronization [Cooper et al., 2001] . In the cochlea, KCNQ2 immunoreactivity also localized to important sensorineural structures: spiral ganglion neurons and their afferent projections towards inner hair cells, which also stained for KCNQ2. There was significant immunolabeling beneath outer hair cells, while those sensory cells had lower levels of KCNQ2 expression. A recent report [Kharkovets et al., 2006] using immunofluorescent labeling showed similar KCNQ2 immunoreactivity in unmyelinated axon fibers under hair cells in mouse cochlea. For KCNQ3, immunolabeling was less intense in the spiral ganglion neurons. In contrast, the perineuronal satellite cells were dis- Fig. 4 . A Characterization of anti-KCNQ3N antiserum and affinity-purified antibody (AP) by Western blot using preimmune and immune sera against KCNQ3 expressed in HEK cells. Immunoreactivity against the ; 90-kDa KCNQ3 band is absent using preimmune serum, while immune serum detects the KCNQ3 protein. After affinity purification, the anti-KCNQ3N antibody recognizes a specific band of ; 90 kDa; this is abolished by preincubation of the antibodies with the KCNQ3 immunogenic peptide (Q3N), whereas KCNQ3N antibodies still recognize the KCNQ3 band in the presence of KCNQ2 peptide (Q2N). B KCNQ3 subunit immunoreactivity in rat spiral ganglion neurons (sgn) and perineuronal satellite cells (black arrow) with nuclei (black arrowhead) was detected by immunoperoxidase (DAB) staining. C Control section with primary antibody (anti-KCNQ3) omitted. D-I Double immunostaining of KCNQ3 (red in D and G ) and TUJ1 (green in E ) or KCNJ10 (green in H ) in the rat spiral ganglion. KCNQ3 immunoreactivity was observed in the somata of sgn (indicated by white star in D and G ) and appeared more pronounced in the surrounding satellite cells (white arrows). In the overlay image ( I ), KCNQ3 and KCNJ10 immunoreactivities were colocalized in the satellite cells (white arrowheads indicating DAPI-stained nuclei). Scale bars = 20 m.
tinctly immunolabeled with the KCNQ3 antiserum. This was somewhat unexpected; however, satellite cell KCNQ3 subunits may form functional channels with an as yet uncharacterized subunit in these cells, and the functional significance may involve removal of potassium from the spiral ganglion neurons. Analogous to the control of intracellular calcium ion concentration ([Ca 2+ ] i ) by KCNQ4 in inner hair cells [Oliver et al., 2003 ], the satellite cell KCNQ3 subunits may participate in release of trophic support factors to spiral ganglion neurons via regulation of [Ca 2+ ] i . KCNQ3 channel proteins were not detected in the organ of Corti and cochlear lateral wall by immunohistochemistry, whereas RT-PCR showed that Kcnq3 mRNA transcripts were present in both cochlear subregions. It is reasonable to assume that in these cochlear partitions KCNQ3 channel subunits exist at a low level which cannot be easily detected by an immunohistochemical approach, which is inferior to RT-PCR in sensitivity and specificity.
KCNQs are clearly involved in auditory function as evidenced by deafness resulting from mutations in KCNQ1 and 4. Here, we provide further support for involvement of KCNQ2 and/or KCNQ3 in M channels with a cochlear distribution, which clearly indicates important roles such as control of auditory sensorineural excitability, possibly synchronization of auditory signaling, and potassium recycling. A potential role in neuron-glia interaction is further suggested. As previously described, other Kcnq genes, e.g. Kcnq5 , and alternatively spliced forms of Kcnq2 , expressed in the cochlea, should contribute to the functional diversity of cochlear M currents [Liang et al., 2005 [Liang et al., , 2006 .
As one of the most common clinical auditory symptoms, tinnitus has been hypothesized as a form of 'sensory epilepsy' [Shea and Harell, 1978] , although the molecular mechanisms underlying tinnitus remain unclear. However, hyperexcitability in the peripheral as well as central auditory system may contribute to the generation of tinnitus [Bauer, 2004] . Immunohistochemical analysis of KCNQ2 and 3 channel subunits showed strong somatic staining in the relay sites of the central auditory pathway, e.g. cochlear nucleus and superior olivary nucleus [Cooper et al., 2001, and unpublished data] . Taken together with our data, it is assumed that dysfunction of M channels, KCNQ2 and 3 in particular, may also be involved in tinnitus pathophysiology. Thus, this work may provide a basis for exciting opportunities for novel therapeutic avenues, e.g. utilizing M channel openers to alleviate tinnitus.
